The number of monkeypox cases in the United States has risen to 21 as of Friday, according to the Centers for Disease Control and Prevention (CDC). The agency’s data show that there are four cases in New York, four in California, three in Florida, two in Colorado, two in Utah, and one each in Georgia, Illinois, Massachusetts,…
Elevated Lung Cancer Risk Linked to Eye Supplement Study Persists 30 Years Later
The National Institute of Health (NIH)’s follow-up study on participants that were part of an eye supplement study has revealed that elevated lung cancer risks linked with the supplement still exist around 30 years later. The study found that though the current Age-Related Eye Disease supplement (AREDS) is effective at slowing the progression macular degeneration,…
Experimental Drug Repairs Neuron Junctions Losses, Gives Hope for Dementia Patients
A study by Yale University has found a Silent Allosteric Modulation (SAM) drug named BMS-984923to be capable of recovering neuronal synapse losses in mice models for Alzheimer’s disease (AD), creating hope for human dementia patients affected by AD. Synapse [neuronal connection] loss “disrupt neural networks and cause cognitive decline seen in Alzheimer’s,” said Dr. Stephen…
How the Decisions to Nix Certain Monoclonal Antibodies Were Made
Monoclonal antibodies have had their share of ups and downs in the timeline of COVID-19 treatments—but according to news headlines spanning the past two years—not nearly as much as some of the other off-label drugs like ivermectin and hydroxychloroquine. Most of the controversy, if any at all, began at the end of last year, when…
Food Allergies Associated With Reduced COVID-19 Infection
A study funded by the National Institutes of Health has found that people with food allergies have reduced risk of COVID-19 infection, being asthmatic conferred no extra risk of infection; but being overweight, obese, or having a high body mass index (BMI) increased the risk of infection. “The observed association between food allergy and the…
Pfizer COVID-19 Pill Does Not Provide Significant Benefit in Patients Under 65: Study
Pfizer’s COVID-19 pill helps reduce COVID-19 hospitalizations and deaths in the elderly but provides no strong benefit for those under 65, according to a new study. Researchers in Israel gleaned data from Clalit Health Services, a health care organization that covers over half of the entire population in the country. They analyzed data from the…
Japan Study Shows Women More Likely to Get Skin Rash From Moderna Shot
TOKYO—A study in Japan found that women were significantly more likely than men to develop rash-like side effects after a first dose of Moderna Inc.’s COVID-19 vaccine. The study of 5,893 participants between May and November last year showed that 22.4 percent of women developed delayed skin reactions after the first shot, compared to 5.1…
Hardening of Heart Valves is a Major Predictor for Mortality, Mayo Clinic Finds
A study by Mayo Clinic has found that a common hardening of valves in the heart, which affected around a quarter of patients checking for heart conditions, increases the risk of mortality as well as cardiovascular disease and valvular disease. “Mitral annulus calcification [hardening of heart valves] has been known to be associated with cardiovascular…
WHO Says Monkeypox May Have Been Spreading Undetected
Officials with the World Health Organization (WHO) say that the sudden rise in monkeypox cases worldwide suggests that it has been spreading in an undetected manner for some time. “We don’t really know whether it’s too late to contain. What WHO and all member states are trying to do is prevent onward spread,” Dr. Rosamund…
Pfizer Asks FDA to Authorize 3 COVID-19 Vaccine Doses for Children Under 5
Pfizer and BioNTech have completed an application for emergency use authorization (EUA) to the Food and Drug Administration (FDA) for a three-dose COVID-19 vaccine regimen for children aged 6 months to under 5 years old. Pfizer announced the completion of its EUA application on Wednesday, reported multiple outlets. The companies initially asked the FDA for an EUA…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`